Recent developments in the subcutaneous ICD

Trends Cardiovasc Med. 2016 Aug;26(6):526-35. doi: 10.1016/j.tcm.2016.03.004. Epub 2016 Mar 15.

Abstract

The subcutaneous implantable cardioverter-defibrillator (ICD) was developed as a simple device to reduce the morbidity of ICD therapy while providing a comparable reduction in sudden death from ventricular fibrillation. This review highlights the differences compared to the traditional ICD. It includes recent data on safety and efficacy, as well as best practices on screening and programming, and discusses expected future developments.

Keywords: Implantable cardioverter-defibrillator; Subcutaneous implantable cardioverter-defibrillator; Sudden cardiac death; Ventricular fibrillation.

Publication types

  • Review

MeSH terms

  • Death, Sudden, Cardiac / etiology
  • Death, Sudden, Cardiac / prevention & control*
  • Defibrillators, Implantable*
  • Diffusion of Innovation
  • Electric Countershock / adverse effects
  • Electric Countershock / instrumentation*
  • Electric Countershock / mortality
  • Humans
  • Patient Safety
  • Prosthesis Design
  • Prosthesis Failure
  • Prosthesis Implantation / adverse effects
  • Prosthesis Implantation / methods*
  • Prosthesis Implantation / mortality
  • Risk Factors
  • Treatment Outcome
  • Ventricular Fibrillation / diagnosis
  • Ventricular Fibrillation / mortality
  • Ventricular Fibrillation / physiopathology
  • Ventricular Fibrillation / therapy*